Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
(S)-(+)-Ibuprofen
Cat. No.:
0225LY-0892
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
(S)-(+)-Ibuprofen is classified as a non-steroidal anti-inflammatory drug (NSAID) that exerts its therapeutic effects by inhibiting the cyclooxygenase (COX) enzyme.
Synonym:
Dexibuprofen; (S)-Ibuprofen; 51146-56-6; (S)-(+)-Ibuprofen; (S)-2-(4-Isobutylphenyl)propanoic acid; S(+)-Ibuprofen; (S)-(+)-2-(4-Isobutylphenyl)propionic acid; Seractil; (+)-(S)-p-Isobutylhydratropic acid; (S)-(+)-4-Isobutyl-alpha-methylphenylacetic acid; MFCD00069289; S-(+)-ibuprofen; (2S)-2-(4-isobutylphenyl)propanoic acid; S-(+)-2-(4-Isobutylphenyl)propionic acid; (+)-Ibuprofen; Dexibuprofene; Dexibuprofeno; Dexibuprofenum; Benzeneacetic acid, alpha-methyl-4-(2-methylpropyl)-, (S)-
CAS No.:
51146-56-6
Compound CID:
39912
Formula:
C13H18O2
Formula Weight:
206.28
Specification
Targets&IC50:
COX-1: 13 μM; COX-2: 370 μM
Relative Density:
1.029 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
(S)-(+)-Ibuprofen can be used in pain research to study the specific enantiomeric inhibition of prostaglandin synthesis.
Library Information
Target:
COX; PPAR; Thrombin; BCL
Receptor:
Bcl-2; COX; Cystic fibrosis transmembrane conductance regulator; PPARγ; Thrombomodulin
Pathways:
DNA damage/DNA repair; Neuronal signaling; Apoptosis; Metabolism; Immunology/Inflammation; Proteases/Proteasome
Plate Number:
AOCL-12
Plate Location:
d11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
25 mg/mL; 121.19 mM
